| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |